Home LiteratureArticle Details
PMID: 9792541 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.

Diabetes ·Vol. 47 ·No. 11 ·1998-11-00 ·Pages 1722-6

Tian YA, Johnson G, Ashcroft SJ

Abstract

Hypoglycemic sulfonylureas stimulate insulin release by binding to a regulatory subunit of plasma membrane ATP-sensitive K+ (K(ATP)) channels. The consequent closure of K(ATP) channels leads to depolarization, opening of voltage-dependent Ca2+ channels, Ca2+ influx, and a rise in intracellular [Ca2+]. Recently, however, it has been suggested that sulfonylureas may have an additional action on secretion, independent of changes in intracellular [Ca2+] but dependent on the activity of protein kinase C (PKC). We have investigated the mechanisms involved in the PKC-dependent effect of sulfonylureas on the secretion machinery in beta-cells. In MIN6 beta-cells permeabilized by streptolysin O, insulin release was stimulated by elevation of [Ca2+] from 10(-8) to 10(-5) mol/l. At a [Ca2+] of 10(-8) mol/l, insulin release from permeabilized beta-cells was stimulated by addition of GTP-gamma-S, or by addition of a phorbol ester, 12-O-tetradecanoylphorbol 13-acetate (TPA). TPA, but not GTP-gamma-S, also increased insulin release when [Ca2+] was 10(-5) mol/l. Insulin release from permeabilized beta-cells was stimulated by tolbutamide (0.1-1 mmol/l) at 10(-8) but not at 10(-5) mol/l Ca2+. The effect of tolbutamide was blocked either by inhibition of PKC or when phorbol ester-sensitive PKC isoforms were maximally stimulated by TPA. Meglitinide and glibenclamide also stimulated insulin release from permeabilized beta-cells. To assess the possibility that direct activation of PKC mediates the exocytotic response to sulfonylureas, we studied the effect of tolbutamide and glibenclamide on PKC activity. Purified brain PKC was not activated by tolbutamide or glibenclamide, whether tested in the absence or presence of phosphatidylserine or TPA, or at low or high [Ca2+]; nor was the total PKC activity in extracts of MIN6 beta-cells affected by tolbutamide. Neither tolbutamide nor glibenclamide elicited translocation of any isoform of PKC in intact or permeabilized beta-cells under conditions in which TPA evoked a marked redistribution of PKC alpha- and epsilon-isoforms. We conclude that although the plasma membrane K(ATP) channel-independent stimulation of exocytosis by sulfonylureas may require functional PKC, the mechanism does not involve a direct activation of the enzyme.

MeSH Terms
Animals Calcium/metabolism,pharmacology Enzyme Activation/drug effects Exocytosis/drug effects Glyburide/pharmacology Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology Hypoglycemic Agents/pharmacology Insulinoma Islets of Langerhans/drug effects,metabolism Isoenzymes/metabolism Mice Pancreatic Neoplasms Phosphatidylserines/pharmacology Potassium Channels/physiology Protein Kinase C/metabolism Sulfonylurea Compounds/pharmacology Tetradecanoylphorbol Acetate/pharmacology Tolbutamide/pharmacology Tumor Cells, Cultured
Chemicals
Hypoglycemic Agents Isoenzymes Phosphatidylserines Potassium Channels Sulfonylurea Compounds Guanosine 5'-O-(3-Thiotriphosphate) Tolbutamide Protein Kinase C Tetradecanoylphorbol Acetate Glyburide Calcium
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tian Y A
Nuffield Department of Clinical Biochemistry, John Radcliffe Hospital, Headington, Oxford, UK.
Johnson G
Ashcroft S J
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
0012-1797
Published
1998-11-00
Pages
1722-6
Language
English
Region
United States
NLM ID
0372763
Subset
IM
Grants
Wellcome Trust · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com